ITEOS THERAPEUTICS INC (ITOS)
US46565G1040 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 123.74M | 251.18M | 284.80M | 848.50M | 336.30M | |||
| Marketable Securities | 364.97M | 280.74M | 328.40M | N/A | N/A | |||
| Receivables | 42.80M | 6.50M | 2.40M | 12.10M | 300.00K | |||
| Other Current Assets | 13.36M | 12.24M | 12.70M | 14.10M | 2.90M | |||
| Total Current Assets | 544.88M | 550.65M | 628.30M | 874.70M | 339.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.89M | 10.73M | 6.80M | 7.40M | 1.40M | |||
| Investments And Advances | 160.20M | 100.54M | 118.20M | N/A | N/A | |||
| Other Non-Current Assets | 1.24M | 1.16M | 600.00K | 600.00K | 400.00K | |||
| Total Non-Current Assets | 178.20M | 116.94M | 126.70M | 10.00M | 5.10M | |||
| TOTAL ASSETS | 723.08M | 667.59M | 755.00M | 884.70M | 344.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 28.21M | 16.87M | 20.60M | 17.90M | 7.50M | |||
| Accounts Payable | 7.15M | 11.29M | 7.70M | 5.10M | 3.00M | |||
| Other Current Liabilities | 1.45M | 11.85M | 13.80M | 281.10M | 4.50M | |||
| Total Current Liabilities | 36.81M | 40.01M | 42.00M | 304.10M | 15.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 54.57M | 52.35M | 49.70M | 27.80M | 6.40M | |||
| Total Non-Current Liabilities | 54.57M | 52.35M | 49.70M | 27.80M | 6.40M | |||
| TOTAL LIABILITIES | 91.39M | 92.36M | 91.70M | 331.90M | 21.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 33.93M | 124.63M | 237.30M | 140.60M | -73.90M | |||
| Additional Paid In Capital | 608.69M | 463.80M | 435.70M | 413.20M | 396.40M | |||
| Common Shares | 37.00K | 36.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -10.97M | -13.24M | -9.60M | -1.00M | 600.00K | |||
| Shares Outstanding | 36.53M | 35.84M | 35.70M | 35.50M | 35.00M | |||
| Tangible Book Value per Share | 17.29 | 16.05 | 18.58 | 15.57 | 9.23 | |||
| Total Shareholders' Equity | 631.69M | 575.23M | 663.30M | 552.80M | 323.20M | |||
| TOTAL LIABILITIES AND EQUITY | 723.08M | 667.59M | 755.00M | 884.70M | 344.60M | |||
| Statistics | ||||||||
| Current Ratio | 14.80 | 13.76 | 14.96 | 2.88 | 22.63 | |||
| Return On Assets (ROA) | -16.77% | -16.87% | 12.81% | 24.25% | -12.59% | |||
| Return On Equity (ROE) | -19.19% | -19.58% | 14.58% | 38.80% | -13.43% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 13.99% | 33.32% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 99.98% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 99.98% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21